Smart Nanoparticles for Drug Delivery: Boundaries and Opportunities.

Various pharmaceutical particles have been used in developing different drug delivery systems ranging from traditional tablets to state-of-the-art nanoparticle formulations. Nanoparticle formulations are unique in that the small size with huge surface area sometimes provides unique properties that larger particles and bulk materials do not have. Nanoparticle formulations have been used in improving the bioavailability of various drugs, in particular, poorly soluble drugs. Nanoparticle drug delivery systems have found their unique applications in targeted drug delivery to tumors. While nanoparticle formulations have been successful in small animal xenograft models, their translation to clinical applications has been very rare. Developing nanoparticle systems designed for targeted drug delivery, e.g., treating tumors in humans, requires clear understanding of the uniqueness of nanoparticles, as well as limitations and causes of failures in clinical applications. It also requires designing novel smart nanoparticle delivery systems that can increase the drug bioavailability and at the same time reduce the drug's side effects.

[1]  F. Schué,et al.  Terminology for biorelated polymers and applications (IUPAC Recommendations 2012) , 2012 .

[2]  Holger Grüll,et al.  In vivo temperature controlled ultrasound-mediated intracellular delivery of cell-impermeable compounds. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Darrell J Irvine,et al.  Drug delivery: One nanoparticle, one kill. , 2011, Nature materials.

[4]  Tonglei Li,et al.  Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Alexander T Florence,et al.  "Targeting" nanoparticles: the constraints of physical laws and physical barriers. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Peter Wust,et al.  Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. , 2010, The Lancet. Oncology.

[7]  David W Grainger,et al.  Connecting drug delivery reality to smart materials design. , 2013, International journal of pharmaceutics.

[8]  E. R. Cooper,et al.  Nanoparticles: A personal experience for formulating poorly water soluble drugs. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Ying Zhang,et al.  Advanced materials and processing for drug delivery: the past and the future. , 2013, Advanced drug delivery reviews.

[10]  R. Weinberg,et al.  The Biology of Cancer , 2006 .

[11]  Jouni Hirvonen,et al.  Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods , 2010, The Journal of pharmacy and pharmacology.

[12]  Kinam Park,et al.  Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Förster resonance energy transfer imaging , 2008, Proceedings of the National Academy of Sciences.

[13]  J. Kelm,et al.  3D cell culture systems modeling tumor growth determinants in cancer target discovery. , 2014, Advanced drug delivery reviews.

[14]  M. Faraday X. The Bakerian Lecture. —Experimental relations of gold (and other metals) to light , 1857, Philosophical Transactions of the Royal Society of London.

[15]  Panos Macheras,et al.  A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. , 2006, International journal of pharmaceutics.

[16]  Seiji Miura,et al.  Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[17]  David Needham,et al.  Reverse engineering of the low temperature-sensitive liposome (LTSL) for treating cancer , 2013 .

[18]  Efstathios Karathanasis,et al.  Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Kinam Park,et al.  Introduction to biomaterials for cancer therapeutics , 2013 .

[20]  R. Jain,et al.  Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Lev Ruzer,et al.  Unattached Fraction of Radon Progeny as an Experimental Tool in the Assessment of the Risk of Nanoparticles , 2012 .

[22]  Kinam Park,et al.  Targeted drug delivery to tumors: myths, reality and possibility. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[23]  A. Bangham,et al.  NEGATIVE STAINING OF PHOSPHOLIPIDS AND THEIR STRUCTURAL MODIFICATION BY SURFACE-ACTIVE AGENTS AS OBSERVED IN THE ELECTRON MICROSCOPE. , 1964, Journal of molecular biology.

[24]  U. Nielsen,et al.  Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. , 2006, Cancer research.

[25]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[26]  Andhra Pradesh,et al.  NANOPARTICLES AS DRUG DELIVERY SYSTEMS , 2012 .

[27]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[28]  Katherine W Ferrara,et al.  Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[29]  P. Cullis,et al.  Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.

[30]  S. Nie,et al.  Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .

[31]  Ali Khademhosseini,et al.  Biocompatibility of engineered nanoparticles for drug delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[32]  D. Crommelin,et al.  Towards more effective advanced drug delivery systems. , 2013, International journal of pharmaceutics.

[33]  Kinam Park,et al.  Analysis on the current status of targeted drug delivery to tumors. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[34]  J. Kreuter,et al.  In vitro studies of poly(methyl methacrylate) adjuvants. , 1976, Journal of pharmaceutical sciences.

[35]  Rahul P Gangwal,et al.  Oral delivery of anticancer drugs: challenges and opportunities. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Harald Schubert,et al.  Pharmacokinetics of temoporfin-loaded liposome formulations: correlation of liposome and temoporfin blood concentration. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[37]  Xiabin Jing,et al.  Photosensitive Pt(IV)-azide prodrug-loaded nanoparticles exhibit controlled drug release and enhanced efficacy in vivo. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[38]  Matthias Wacker,et al.  Nanocarriers for intravenous injection--the long hard road to the market. , 2013, International journal of pharmaceutics.

[39]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[40]  Lei Gao,et al.  Drug nanocrystals: In vivo performances. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[41]  Jun Wang,et al.  Rosiglitazone-loaded nanospheres for modulating macrophage-specific inflammation in obesity. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[42]  Kinam Park,et al.  Facing the truth about nanotechnology in drug delivery. , 2013, ACS nano.

[43]  Henry C. Pitot,et al.  The Biology of Cancer. Second Edition. By Robert A. Weinberg. New York: Garland Science (Taylor & Francis Group). $150.00 (paper). xx + 876 p.; ill.; A:1-A:6; G:1-G:30; I:1-I:28 (index). ISBN: 978-0-8153-4220-5. [A DVD-ROM accompanies the book.] 2014. , 2014 .

[44]  Li Li,et al.  A novel two-step mild hyperthermia for advanced liposomal chemotherapy. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[45]  Y Li,et al.  PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[46]  Holger Grüll,et al.  Real-time imaging and kinetics measurements of focused ultrasound-induced extravasation in skeletal muscle using SPECT/CT. , 2013, Journal of controlled release : official journal of the Controlled Release Society.